Find our clinical program for a type of cancer:

Hendrik W. van Deventer, M.D., M.S.

Assistant Professor
Immunology
Hematology/Oncology

Research Interests
Chemokines, tumor immunology and immunotherapy
Leukemia, lymphoma, myeloma, myelodysplastic and myeloproliferative syndromes.

Recent Accomplishments and Honors
Fellowship: University of North Carolina, Chapel Hill, North Carolina Hematology/Oncology

Chief Medical Residency: University of Michigan, Ann Arbor, Michigan Internal Medicine

Residency: University of Michigan, Ann Arbor, Michigan Internal Medicine

Training
MD: Medical College of Virginia, Richmond, VA

MS: University of North Carolina, Chapel Hill, North Carolina Mathematics

BS: Davidson College, Davidson, North Carolina

Publications
Dees EC, McKinnon KP, Kuhns JJ, Chwastiak KA, Sparks S, Myers M, Collins EJ, Frelinger JA, van Deventer H, Collichio F, Carey LA, Brecher ME, Graham M, Earp HS, Serody JS.Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer. Cancer Immunol Immunother. 2004 Jun 8

Wong A, Brickey W, Taxman D, van Deventer H, Reed W, Gao J, Zheng P, Liu Y, Li P, Blum, J, McKinnon K, Ting J. CIITA-regulated Plexin-A1 Affects T-Cell-Dendritic Cell Interactions. Nat Immunol Aug 10, 2003 4(9):891-8

Ng-Cashin J, Kuhns J, Burkett S, Powderly J, Craven R, van Deventer H, Kirby S, Serody J. Host Absence of CCR5 Potentiates Dendritic Cell Vaccination J of Imm 170(8):4201 2003.

van Deventer H, Hall M, Orlowski R, et. al., The Clinical Course of Thrombocytopenia in Accelerated Phase Chronic Myelogenous Leukemia for Patients Treated with Imatinib Am J of Hem 71(3):184 2002.

van Deventer. H, Serody J, McKinnon K, et. al., Transfection of Macrophage Inflammatory Protein 1a (MIP-1a) into B16-F10 Melanoma Cells Inhibits Growth of Pulmonary Metastases but not Subcutaneous Tumors J of Imm 169(3):1634 2002.

van Deventer H, Shea T. Use of Growth Factors to Increase Dose Intensity. Clinical Application of Cytokines and Growth Factors, Kluwer Academic Publishers 1999.

Click here for a list of Publications on PubMed

E-mail: hvand@med.unc.edu
Telephone: 966-4431
FAX: 966-6735
Address: UNC Chapel Hill, Division of Hematology/Oncology, 3009 Old Clinic Buil Chapel Hill, NC 27599-7305

Click here to update this profile

University Cancer Research Fund Line Find a Clinical Trial Line New Hospital Taking Shape Line Events Line Make a Gift Line NCI Designated Cancer Center